Legal & General Group’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Legal & General Group’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,857	Closed	-$147K	–	2914
2016 Q2	$147K	Buy	+4,857	New	+$98.6K	﹤0.01%	1897

Legal & General Group's CPXX Position: Q3 2016 in Review

Legal & General Group sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 4,857 shares — an estimated $147K sold.

Legal & General Group first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $147K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Legal & General Group reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Legal & General Group sold 4,857 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $147K.
Legal & General Group first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
Legal & General Group's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $147K in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Legal & General Group's 13F filing for Q3 2016, filed 12 Oct 2016.